+ |
CCL5 | up-regulates
binding
|
CCR1 |
0.764 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-254367 |
|
|
Homo sapiens |
|
pmid |
sentence |
10734056 |
RANTES interacts with specific cell surface receptors, which are coupled to pertussis toxin-sensitive guanine nucleotide regulatory proteins (G protein) to activate effectors such as phospholipase C (PLC), ion channels, phospholipase D, and protein kinase C. In addition to the CCR1 receptor, RANTES activates several members of the CC subfamily of chemokine receptors including CCR3, CCR4, and CCR5 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CCL5 | up-regulates
binding
|
CCR3 |
0.76 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-254370 |
|
|
Homo sapiens |
|
pmid |
sentence |
10734056 |
In addition to the CCR1 receptor, RANTES activates several members of the CC subfamily of chemokine receptors including CCR3, CCR4, and CCR5 |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CCL5 | up-regulates
|
Metastasis |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277729 |
|
|
Homo sapiens |
Pancreatic Cancer Cell |
pmid |
sentence |
38339310 |
This suggests CCL5 not only remodels the PDAC TME to benefit tumor cells, but can also enhance the tumor cell’s metastatic potential. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CCL5 | up-regulates activity
binding
|
CCR5 |
0.936 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277726 |
|
|
Homo sapiens |
Pancreatic Cancer Cell |
pmid |
sentence |
38339310 |
CCL5, also known RANTES (regulated on activation, normal T cell expressed and secreted), is a potent chemoattractant for a variety of leukocytes, including T cells, mono- cytes, NK cells, and basophils, signaling via the CCR1, CCR3, and CCR5 cell surface receptors [59]. Among these receptors, CCL5 has the highest affinity for CCR5. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
FOXP3 | up-regulates quantity by expression
transcriptional regulation
|
CCL5 |
0.447 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-277727 |
|
|
Homo sapiens |
Pancreatic Cancer Cell |
pmid |
sentence |
38339310 |
Given its role as a potent chemoattractant for T cells, CCL5 can be utilized to attract Tregs to malignant epithelial cells. Wang et al. demonstrated that Forkheadbox protein 3 (FOXP3), a key transcription factor for Tregs, was highly ex- pressed in pancreatic cancer cell lines, which, in turn, upregulated CCL5 expression |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
maraviroc | down-regulates
chemical inhibition
|
CCL5 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-194127 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
IRX2 | down-regulates quantity by repression
transcriptional regulation
|
CCL5 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266043 |
|
|
Homo sapiens |
Hs-578T Cell |
pmid |
sentence |
26560478 |
Our results imply that the IRX2 transcription factor might represent a novel metastasis associated protein that acts as a negative regulator of cellular motility and as a repressor of chemokine expression. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |